Network for Neuroblastoma and CNS Tumor Research in Children
Annual Meeting in Uppsala
Date:
Location:
9-10 November, 2026
Clarion Hotel Gillet
Deadline for Registration and Abstract submission is 18 September, 2026.
Submit to abstract@nbcns.se
Institute of Cancer Research
Sutton, UK
Dr George is a Paediatric Oncologist and a CRUK Clinician Scientist with an interest in paediatric solid tumours, specifically the common, poor outcome childhood tumour, neuroblastoma.
St. Anna's Children's Research Institute, Vienna, Austria
Dr. Tascher-Mandl's lab tackles unresolved questions of neuroblastoma pathogenesis and develops new diagnostic and therapeutic approaches to facilitate precision medicine for children with malignant tumors.
Smurfit Institute of Genetics,
Trinity College, Dublin, Ireland
Dr. Bracken's lab is focused on understanding the molecular mechanisms of how Polycomb group proteins regulate cell-fate decisions and cancer.
St. Jude's Children's Research Hospital, Memphis, USA
Dr. Robinson's lab is focused on improved survival and reduced morbidity of children with medullosblastoma and other central nervous system tumors using genomic analysis.
St. Jude's Children's Research Hospital, Memphis, USA
Dr. Northcott's lab studies genetics and preclinical models for treatment development, and uses translational genomics for improving outcomes of children with malignant brain tumors.
info@nbcns.se
